UMIN ID: UMIN000055471
Registered date:15/09/2024
The association between Fibrosis index 4 and renal dysfuction in type 2 diabetes taking SGLT2 inhibitors
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Type 2 diabetes |
| Date of first enrollment | 2024/08/23 |
| Target sample size | 130 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Is there any differecnces in the occurence of renal dysfunction according to the FIB-4 |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | nothing |
Related Information
| Primary Sponsor | Tokyo Bay Urayasu Ichikawa Medical Center |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Tokyo Bay Urayasu Ichikawa Medical Center |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Keisuke Takano |
| Address | 3-4-32, Todaijima, Urayasu city, Chiba Japan 2790001 |
| Telephone | 047-351-3101 |
| kt900928@gmail.com | |
| Affiliation | Tokyo Bay Urayasu Ichikawa Medical Center Department of Nephrology, Endocrinology and Diabetes |
| scientific contact | |
| Name | Toshihiko Suzuki |
| Address | 3-4-32, Todaijima, Urayasu city, Chiba Japan |
| Telephone | 047-351-3101 |
| toshi-s@xj9.so-net.ne.jp | |
| Affiliation | Tokyo Bay Urayasu Ichikawa Medical Center Department of Nephrology, Endocrinology and Diabetes |